ビタミン D 検査の市場規模、シェア、分析：検査タイプ別 (25-ヒドロキシ ビタミン D 検査、1,25-ジヒドロキシ ビタミン D 検査)、技術別 (ラジオイムノアッセイ、ELISA、HPLC、LC-MS、その他)、患者別（小児、成人）、適応症別（骨粗鬆症、くる病、甲状腺疾患、ビタミンD欠乏症、その他）、エンドユーザー別（病院、診断研究所、在宅医療、その他）および地域予測、2022〜2032年
ビタミン D検査は、人間の血液中のビタミン D レベルを測定し、体がうまく機能するために十分なビタミン D レベルがあることを確認します。ビタミンDは、健康な歯と骨の両方にとって非常に重要です。また、人間の神経、筋肉、免疫系の機能を正常に保つのにも役立ちます。ビタミンDレベルの低下は、骨疾患やその他の医学的問題を引き起こす一般的な問題です。ビタミン D 検査は、患者のビタミン D レベルを示します。
ビタミンD検査市場は12億ドルに達すると予想され、栄養不足の影響に関する成長、老若男女の慢性疾患症例の増加、および高齢者人口の増加により、予測期間中は5.5％のCAGRで成長すると予想されます。ビタミンD欠乏症の有病率は拡大しており、その重要性がより認識されるようになり、それがビタミンD血清レベルのスクリーニングの増加につながり、ビタミンD検査市場を押し上げています。
目次
1.Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Vitamin D Testing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1.Market Definition
3.2.Vitamin D Testing Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.Vitamin D Testing Market - Industry Insights
4.1. Industry Segmentation
4.2.COVID-19 overview on world economy
4.3.Industry ecosystem Channel analysis
4.4.Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8. Market Analysis
8.1. Porters Five Forces
8.2.PEST Analysis
8.2.1.Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. Vitamin D Testing Market
9.1.Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. Vitamin D Testing Market Size & Forecast 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1.By Test Type
10.3.1.1.25-Hydroxy Vitamin D Test
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2.Market Share (%) 2022-2032F
10.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.1.2. 1,25-Dihydroxy Vitamin D Test
10.3.1.2.1.By Value (USD Million) 2022-2032F
10.3.1.2.2. Market Share (%) 2022-2032F
10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2. By Technique
10.3.2.1. Radioimmunoassay
10.3.2.1.1.By Value (USD Million) 2022-2032F
10.3.2.1.2. Market Share (%) 2022-2032F
10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.2.ELISA
10.3.2.2.1. By Value (USD Million) 2022-2032F
10.3.2.2.2.Market Share (%) 2022-2032F
10.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.3.HPLC
10.3.2.3.1. By Value (USD Million) 2022-2032F
10.3.2.3.2.Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.LC-MS
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Others
10.3.2.5.1. By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.3. By Patient
10.3.3.1. Pediatric
10.3.3.1.1.By Value (USD Million) 2022-2032F
10.3.3.1.2. Market Share (%) 2022-2032F
10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Adult
10.3.3.2.1. By Value (USD Million) 2022-2032F
10.3.3.2.2.Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.4. By Indications
10.3.4.1.Osteoporosis
10.3.4.1.1.By Value (USD Million) 2022-2032F
10.3.4.1.2. Market Share (%) 2022-2032F
10.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.4.2.Rickets
10.3.4.2.1. By Value (USD Million) 2022-2032F
10.3.4.2.2.Market Share (%) 2022-2032F
10.3.4.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.3.Thyroid Disorders
10.3.4.3.1. By Value (USD Million) 2022-2032F
10.3.4.3.2.Market Share (%) 2022-2032F
10.3.4.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.4. Vitamin D Deficiency
10.3.4.4.1. By Value (USD Million) 2022-2032F
10.3.4.4.2.Market Share (%) 2022-2032F
10.3.4.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.5.Others
10.3.4.5.1. By Value (USD Million) 2022-2032F
10.3.4.5.2.Market Share (%) 2022-2032F
10.3.4.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.5. By End User
10.3.5.1. Hospitals
10.3.5.1.1.By Value (USD Million) 2022-2032F
10.3.5.1.2. Market Share (%) 2022-2032F
10.3.5.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.5.2.Diagnostic Laboratories
10.3.5.2.1. By Value (USD Million) 2022-2032F
10.3.5.2.2.Market Share (%) 2022-2032F
10.3.5.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.5.3.Homecare
10.3.5.3.1. By Value (USD Million) 2022-2032F
10.3.5.3.2.Market Share (%) 2022-2032F
10.3.5.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.5.4.Others
10.3.5.4.1. By Value (USD Million) 2022-2032F
10.3.5.4.2.Market Share (%) 2022-2032F
10.3.5.4.3.Y-o-Y Growth (%) 2022-2032F
11. North America Vitamin D Testing Market Size & Forecast 2022A-2032F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Test Type
11.3.2. By Technique
11.3.3.By Patient
11.3.4.By Indications
11.3.5.By End User
11.4. Country
11.4.1.United States
11.4.2. Canada
12. Europe Vitamin D Testing Market Size & Forecast 2022A-2032F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Technique
12.3.3.By Patient
12.3.4. By Indications
12.3.5.By End User
12.4. Country
12.4.1. Germany
12.4.2.United Kingdom
12.4.3.France
12.4.4.Italy
12.4.5.Spain
12.4.6.Russia
12.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. Asia Vitamin D Testing Market Size & Forecast 2022A-2032F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Test Type
13.3.2.By Technique
13.3.3.By Patient
13.3.4. By Indications
13.3.5.By End User
13.4. Country
13.4.1. India
13.4.2.China
13.4.3.South Korea
13.4.4.Japan
13.4.5.Rest of APAC
14. Middle East and Africa Vitamin D Testing Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Test Type
14.3.2. By Technique
14.3.3. By Patient
14.3.4. By Indications
14.3.5. By End User
14.4.Country
14.4.1. Israel
14.4.2.GCC
14.4.3.North Africa
14.4.4.South Africa
14.4.5.Rest of Middle East and Africa
15. Latin America Vitamin D Testing Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Test Type
15.3.2.By Technique
15.3.3.By Patient
15.3.4. By Indications
15.3.5. By End User
15.4.Country
15.4.1. Mexico
15.4.2.Brazil
15.4.3.Rest of Latin America
16. Competitive Landscape
16.1.Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. Company Profiles
17.1.Thermo Fisher Scientific Inc.
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Abbott
17.3. Siemens Healthineers AG
17.4.Roche Diagnostics USA
17.5.Quest Diagnostics Incorporated
17.6. BIOMÉRIEUX
17.7. Beckman Coulter Inc.
17.8.Tosoh Bioscience Inc.
17.9. Quidel Corporation
17.10. DiaSorin S.p.A.
17.11.Everly Health
17.12. DiaSys Diagnostic Systems GmbH
17.13. Qualigen Therapeutics Inc.
17.14.OmegaQuant
17.15. Biohit Healthcare
17.16. Other Prominent Players
18. Appendix
19. Consultant Recommendation
